8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
May 6, 2026·SEC
Material company update
Feb 25, 2026·SEC
Penumbra, Inc.(PEN)Earnings, Financials & Key Ratios
PEN•NYSE
70.2× P/E·Price updated Jun 19, 2026
AboutPenumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.Show more
- Revenue$1.4B+17.5%
- EBITDA$207M+526.8%
- Net Income$178M+1168.1%
- EPS (Diluted)4.52+1155.6%
- Gross Margin67.14%+6.2%
- EBITDA Margin14.73%+433.4%
- Operating Margin13.48%+1635.9%
- Net Margin12.66%+979.3%
- ROE13.78%+1045.8%
PEN Key Insights
Penumbra, Inc. (PEN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 20.2%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when PEN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
PEN Price & Volume
Penumbra, Inc. (PEN) stock price & volume — 10-year historical chart
Loading chart...
PEN Growth Metrics
Penumbra, Inc. (PEN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years22.39%
5 Years20.16%
3 Years18.33%
TTM17.27%
Profit CAGR
10 Years54.02%
5 Years-
3 Years-
TTM305.01%
EPS CAGR
10 Years49.69%
5 Years-
3 Years-
TTM309.43%
Return on Capital
10 Years2.14%
5 Years3.7%
3 Years6.27%
Last Year12.54%
PEN Recent Earnings
Penumbra, Inc. (PEN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.82-21.2%
$1.04
Rev
$375M+1.2%
$370M
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$1.18+6.3%
$1.11
Rev
$385M+6.5%
$362M
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$0.97+4.4%
$0.93
Rev
$355M+4.0%
$341M
Q3 2025
Jul 29, 2025Metric
Actual
Est
EPS
$0.86+6.2%
$0.81
Rev
$339M-0.6%
$341M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.82vs $1.04-21.2% | $375Mvs $370M+1.2% |
| Q1 2026 | Feb 25, 2026 | $1.18vs $1.11+6.3% | $385Mvs $362M+6.5% |
| Q4 2025 | Nov 5, 2025 | $0.97vs $0.93+4.4% | $355Mvs $341M+4.0% |
| Q3 2025 | Jul 29, 2025 | $0.86vs $0.81+6.2% | $339Mvs $341M-0.6% |
Based on last 12 quarters of dataView full earnings history →
PEN Peer Comparison
Penumbra, Inc. (PEN) competitors in Neuromodulation and neuro devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ISRG | 144.48B | 406.78 | 51.69 | 20.51% | 28.15% | 16.89% | 0.02 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 NVST | 4.22B | 25.91 | 92.54 | 8.32% | 2.41% | 2.18% | 0.55 | |
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 | |
 SYK | 117.88B | 307.80 | 36.64 | 11.16% | 12.92% | 15.04% | 0.66 | |
 BSX | 67.31B | 45.29 | 23.35 | 19.87% | 14.4% | 12.4% | 0.51 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 | |
 EW | 50.37B | 87.36 | 47.74 | 11.55% | 17.64% | 10.35% | 0.07 |
Compare PEN vs Peers
Penumbra, Inc. (PEN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PEN Income Statement
Penumbra, Inc. (PEN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 333.76M | 444.94M | 547.4M | 560.41M | 747.59M | 847.13M | 1.06B | 1.19B | 1.4B | 1.45B |
Revenue Growth % | 26.75% | 33.31% | 23.03% | 2.38% | 33.4% | 13.32% | 24.95% | 12.86% | 17.5% | 17.27% |
Cost of Goods Sold | 116.62M | 152.41M | 175.44M | 222.24M | 272.21M | 311.93M | 375.88M | 439.62M | 461.23M | 474.32M |
COGS % of Revenue | 34.94% | 34.25% | 32.05% | 39.66% | 36.41% | 36.82% | 35.51% | 36.8% | 32.86% | - |
Gross Profit | 217.14M▲ 0% | 292.53M▲ 34.7% | 371.96M▲ 27.2% | 338.18M▼ 9.1% | 475.38M▲ 40.6% | 535.21M▲ 12.6% | 682.64M▲ 27.5% | 755M▲ 10.6% | 942.44M▲ 24.8% | 979.97M▲ 0% |
Gross Margin % | 65.06% | 65.75% | 67.95% | 60.34% | 63.59% | 63.18% | 64.49% | 63.2% | 67.14% | 67.38% |
Gross Profit Growth % | 27.11% | 34.72% | 27.15% | -9.08% | 40.57% | 12.58% | 27.55% | 10.6% | 24.83% | - |
Operating Expenses | 215.98M | 293.38M | 324.46M | 377.12M | 482.88M | 529.13M | 609.09M | 745.72M | 753.19M | 792.83M |
OpEx % of Revenue | 64.71% | 65.94% | 59.27% | 67.29% | 64.59% | 62.46% | 57.54% | 62.42% | 53.66% | - |
Selling, General & Admin | 184.32M | 226.38M | 272.73M | 287.07M | 378.33M | 449.72M | 506.45M | 573.99M | 663.42M | 702.76M |
SG&A % of Revenue | 55.22% | 50.88% | 49.82% | 51.22% | 50.61% | 53.09% | 47.85% | 48.05% | 47.26% | - |
Research & Development | 31.66M | 36.16M | 51.72M | 90.05M | 104.55M | 79.41M | 84.42M | 94.78M | 89.77M | 90.07M |
R&D % of Revenue | 9.49% | 8.13% | 9.45% | 16.07% | 13.99% | 9.37% | 7.98% | 7.93% | 6.4% | - |
Other Operating Expenses | 0 | 30.84M | 0 | 0 | 0 | 0 | 18.21M | 76.94M | 0 | 0 |
Operating Income | 1.17M▲ 0% | -852K▼ 173.1% | 47.51M▲ 5676.1% | -38.94M▼ 182.0% | -7.5M▲ 80.7% | 6.08M▲ 181.1% | 73.55M▲ 1109.3% | 9.28M▼ 87.4% | 189.25M▲ 1939.5% | 187.13M▲ 0% |
Operating Margin % | 0.35% | -0.19% | 8.68% | -6.95% | -1% | 0.72% | 6.95% | 0.78% | 13.48% | 12.87% |
Operating Income Growth % | 186.3% | -173.13% | 5676.06% | -181.97% | 80.74% | 181.08% | 1109.32% | -87.38% | 1939.54% | - |
EBITDA | 4.95M | 5.32M | 55.61M | -26.05M | 8.91M | 30.4M | 100.81M | 32.98M | 206.72M | 199.59M |
EBITDA Margin % | 1.48% | 1.19% | 10.16% | -4.65% | 1.19% | 3.59% | 9.52% | 2.76% | 14.73% | 13.72% |
EBITDA Growth % | 422.28% | 7.48% | 946.12% | -146.84% | 134.19% | 241.34% | 231.57% | -67.28% | 526.79% | 239.86% |
D&A (Non-Cash Add-back) | 3.78M | 6.17M | 8.1M | 12.89M | 16.41M | 24.32M | 27.26M | 23.7M | 17.47M | 12.46M |
EBIT | 1.17M | 29.98M | 47.51M | -38.94M | -8.57M | 5.64M | 81.39M | 22.29M | 205.13M | 200.16M |
Net Interest Income | 2.65M | 2.96M | 2.85M | 1.27M | 938K | 137K | 5.09M | 12.27M | 0 | 7.69M |
Interest Income | 2.65M | 2.96M | 2.85M | 1.27M | 2.87M | 1.89M | 6.83M | 13.69M | 0 | 8.35M |
Interest Expense | 0 | 0 | 0 | 0 | 1.93M | 1.75M | 1.74M | 1.42M | 0 | 657K |
Other Income/Expense | 1.31M | 2.46M | 2.63M | 924K | -3M | -2.19M | 6.1M | 11.59M | 15.88M | 15.82M |
Pretax Income | 2.48M▲ 0% | 1.61M▼ 35.1% | 50.13M▲ 3017.8% | -38.02M▼ 175.8% | -10.5M▲ 72.4% | 3.89M▲ 137.1% | 79.65M▲ 1946.5% | 20.87M▼ 73.8% | 205.13M▲ 882.9% | 202.96M▲ 0% |
Pretax Margin % | 0.74% | 0.36% | 9.16% | -6.78% | -1.4% | 0.46% | 7.52% | 1.75% | 14.61% | 13.96% |
Income Tax | -3.61M | -4.4M | 3.13M | -18.76M | -13.13M | 5.89M | -11.3M | 6.86M | 27.44M | 31.91M |
Effective Tax Rate % | -145.84% | -273.82% | 6.25% | 49.35% | 124.98% | 151.44% | -14.19% | 32.86% | 13.38% | 15.72% |
Net Income | 4.66M▲ 0% | 6.6M▲ 41.7% | 48.46M▲ 634.1% | -15.7M▼ 132.4% | 5.28M▲ 133.7% | -2M▼ 137.9% | 90.95M▲ 4643.2% | 14.01M▼ 84.6% | 177.69M▲ 1168.1% | 171.05M▲ 0% |
Net Margin % | 1.4% | 1.48% | 8.85% | -2.8% | 0.71% | -0.24% | 8.59% | 1.17% | 12.66% | 11.76% |
Net Income Growth % | -68.56% | 41.74% | 634.1% | -132.4% | 133.65% | -137.89% | 4643.16% | -84.59% | 1168.11% | 305.01% |
Net Income (Continuing) | 6.09M | 6.01M | 47M | -19.26M | 2.62M | -2M | 90.95M | 14.01M | 177.69M | 171.05M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 175K | -279K | -3.71M | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.13▲ 0% | 0.18▲ 38.5% | 1.34▲ 644.4% | -0.54▼ 140.3% | 0.14▲ 125.9% | -0.05▼ 137.8% | 2.32▲ 4485.6% | 0.36▼ 84.5% | 4.52▲ 1155.6% | 4.33▲ 0% |
EPS Growth % | -70.45% | 38.46% | 644.44% | -140.3% | 125.93% | -137.79% | 4485.63% | -84.48% | 1155.56% | 309.43% |
EPS (Basic) | 0.14 | 0.18 | 1.39 | -0.54 | 0.14 | -0.05 | 2.37 | 0.36 | 4.57 | - |
Diluted Shares Outstanding | 35.32M | 36.09M | 36.27M | 35.77M | 37.88M | 37.84M | 39.22M | 39.27M | 39.29M | 39.54M |
Basic Shares Outstanding | 32.98M | 36.09M | 34.75M | 35.77M | 36.76M | 37.84M | 38.4M | 38.63M | 38.92M | 39.28M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
PEN Balance Sheet
Penumbra, Inc. (PEN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 382.23M | 410.73M | 463.13M | 617.7M | 681.47M | 755.7M | 915.4M | 951.13M | 1.22B | 1.28B |
Cash & Short-Term Investments | 214.59M | 200.89M | 189.39M | 264.83M | 254.88M | 188.03M | 289.19M | 340.13M | 186.9M | 241.29M |
Cash Only | 50.64M | 67.85M | 72.78M | 69.67M | 59.38M | 69.86M | 167.49M | 324.4M | 186.9M | 241.29M |
Short-Term Investments | 163.95M | 133.04M | 116.61M | 195.16M | 195.5M | 118.17M | 121.7M | 15.73M | 0 | 0 |
Accounts Receivable | 58.01M | 81.9M | 105.9M | 114.61M | 133.94M | 203.38M | 201.77M | 167.67M | 190.02M | 183.29M |
Days Sales Outstanding | 63.44 | 67.18 | 70.61 | 74.64 | 65.39 | 87.63 | 69.57 | 51.23 | 49.41 | 45.95 |
Inventory | 94.9M | 115.74M | 152.99M | 219.53M | 263.5M | 334.01M | 388.02M | 406.74M | 431.55M | 438.54M |
Days Inventory Outstanding | 297.02 | 277.19 | 318.3 | 360.55 | 353.33 | 390.84 | 376.79 | 337.7 | 341.51 | 332.84 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 30.28M | 36.42M | 36.59M | 408.22M | 412.28M |
Total Non-Current Assets | 94.43M | 104.28M | 202.77M | 205.28M | 562.78M | 615.19M | 640.9M | 582.06M | 609.84M | 623.03M |
Property, Plant & Equipment | 30.9M | 35.41M | 135.45M | 127.43M | 227.09M | 280.41M | 280.5M | 268.45M | 317M | 329.54M |
Fixed Asset Turnover | 10.80x | 12.57x | 4.04x | 4.40x | 3.29x | 3.02x | 3.77x | 4.45x | 4.43x | 4.74x |
Goodwill | 8.18M | 7.81M | 7.66M | 8.37M | 166.39M | 166.05M | 166.27M | 165.83M | 166.75M | 166.59M |
Intangible Assets | 23.78M | 27.25M | 25.41M | 10.64M | 90.62M | 91.72M | 83.09M | 6.51M | 6.19M | 5.95M |
Long-Term Investments | 3.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 1.02M | 875K | 2.95M | 8.71M | 12.98M | 12.79M | 25.88M | 141.27M | 119.9M | 120.96M |
Total Assets | 476.67M▲ 0% | 515.01M▲ 8.0% | 665.9M▲ 29.3% | 822.98M▲ 23.6% | 1.24B▲ 51.2% | 1.37B▲ 10.2% | 1.56B▲ 13.5% | 1.53B▼ 1.5% | 1.83B▲ 19.1% | 1.9B▲ 0% |
Asset Turnover | 0.70x | 0.86x | 0.82x | 0.68x | 0.60x | 0.62x | 0.68x | 0.78x | 0.77x | 0.81x |
Asset Growth % | 54.63% | 8.04% | 29.3% | 23.59% | 51.19% | 10.18% | 13.53% | -1.49% | 19.13% | 65.36% |
Total Current Liabilities | 51.58M | 66.06M | 91.05M | 105.93M | 123.2M | 144.93M | 151.14M | 158.34M | 183.13M | 211.73M |
Accounts Payable | 6.76M | 8.18M | 15.11M | 14.11M | 13.42M | 26.68M | 27.16M | 31.33M | 34.74M | 43.66M |
Days Payables Outstanding | 21.15 | 19.58 | 31.44 | 23.17 | 18 | 31.22 | 26.37 | 26.01 | 27.49 | 26.23 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.23M | 16.53M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 9.16M | 6.99M | 0 | 0 | 0 |
Other Current Liabilities | 8.88M | 9.3M | 1.82M | 9.81M | 0 | 0 | 0 | 112.43M | 132.16M | 151.54M |
Current Ratio | 7.41x | 6.22x | 5.09x | 5.83x | 5.53x | 5.21x | 6.06x | 6.01x | 6.64x | 6.02x |
Quick Ratio | 5.57x | 4.47x | 3.41x | 3.76x | 3.39x | 2.91x | 3.49x | 3.44x | 4.29x | 3.95x |
Cash Conversion Cycle | 339.31 | 324.79 | 357.47 | 412.02 | 400.73 | 447.25 | 420 | 362.92 | 363.44 | 352.55 |
Total Non-Current Liabilities | 24.68M | 26.53M | 89.24M | 79.26M | 167.13M | 227.1M | 226.22M | 223.91M | 215.78M | 212.9M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 203.47M | 199.65M |
Capital Lease Obligations | 0 | 0 | 73.99M | 71.25M | 163.57M | 223.82M | 220.91M | 208.8M | 0 | 406.81M |
Deferred Tax Liabilities | 3.3M | 4.17M | 4M | 4.78M | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 21.38M | 22.36M | 11.24M | 3.23M | 3.56M | 3.28M | 5.31M | 15.11M | 12.32M | 13.25M |
Total Liabilities | 76.26M | 92.59M | 180.29M | 185.19M | 290.32M | 372.03M | 377.36M | 382.25M | 398.92M | 424.63M |
Total Debt | 0 | 0 | 82.3M | 77.28M | 173.55M | 235.77M | 234.34M | 223.39M | 219.7M | 216.18M |
Net Debt | -50.64M | -67.85M | 9.52M | 7.61M | 114.17M | 165.91M | 66.86M | -101.02M | 32.8M | -25.11M |
Debt / Equity | - | - | 0.17x | 0.12x | 0.18x | 0.24x | 0.20x | 0.19x | 0.15x | 0.15x |
Debt / EBITDA | - | - | 1.48x | - | 19.48x | 7.75x | 2.32x | 6.77x | 1.06x | 1.08x |
Net Debt / EBITDA | -10.24x | -12.76x | 0.17x | - | 12.82x | 5.46x | 0.66x | -3.06x | 0.16x | -0.13x |
Interest Coverage | - | - | - | - | -4.43x | 3.23x | 46.80x | 15.72x | - | 304.65x |
Total Equity | 400.41M▲ 0% | 422.42M▲ 5.5% | 485.61M▲ 15.0% | 637.79M▲ 31.3% | 953.93M▲ 49.6% | 998.86M▲ 4.7% | 1.18B▲ 18.0% | 1.15B▼ 2.4% | 1.43B▲ 24.0% | 1.47B▲ 0% |
Equity Growth % | 50.22% | 5.5% | 14.96% | 31.34% | 49.57% | 4.71% | 18.03% | -2.38% | 24.04% | 80.02% |
Book Value per Share | 11.34 | 11.71 | 13.39 | 17.83 | 25.18 | 26.40 | 30.06 | 29.31 | 36.33 | 37.27 |
Total Shareholders' Equity | 400.41M | 422.24M | 485.89M | 641.5M | 953.93M | 998.86M | 1.18B | 1.15B | 1.43B | 1.47B |
Common Stock | 33K | 34K | 35K | 36K | 37K | 38K | 39K | 38K | 39K | 39K |
Retained Earnings | 2M | 9.06M | 57.52M | 40.62M | 45.91M | 43.9M | 134.86M | 60M | 237.69M | 270.27M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 1.57M | -1.94M | -2.32M | 2.54M | -2.63M | -8.12M | -3.15M | -5.84M | 4.35M | 2.08M |
Minority Interest | 0 | 175K | -279K | -3.71M | 0 | 0 | 0 | 0 | 0 | 0 |
PEN Cash Flow Statement
Penumbra, Inc. (PEN) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 12.69M | 28.81M | 26.65M | -33.24M | 9.5M | -55.66M | 97.33M | 168.48M | 238.66M | 276.66M |
Operating CF Margin % | 3.8% | 6.47% | 4.87% | -5.93% | 1.27% | -6.57% | 9.2% | 14.1% | 17% | - |
Operating CF Growth % | 199.09% | 127% | -7.48% | -224.73% | 128.58% | -685.78% | 274.87% | 73.1% | 41.66% | 248.78% |
Net Income | 4.66M | 2.91M | 48.46M | -19.26M | 5.28M | -2M | 90.95M | 14.01M | 177.69M | 171.05M |
Depreciation & Amortization | 3.78M | 6.17M | 7.85M | 12.89M | 19.49M | 27.57M | 30.61M | 23.7M | 17.47M | 17.03M |
Stock-Based Compensation | 17.81M | 18.42M | 0 | 25.54M | 0 | 0 | 0 | 46.16M | 59.21M | 45.43M |
Deferred Taxes | -4.29M | -6.48M | 1.82M | -18.82M | -14.09M | 1.46M | -19.06M | -16.34M | 21.03M | 22.3M |
Other Non-Cash Items | 4.22M | 38.05M | 25.36M | 17.59M | 65.53M | 38.84M | 73.92M | 124.72M | 5.97M | 195.79M |
Working Capital Changes | -13.49M | -30.26M | -56.84M | -51.19M | -66.71M | -121.53M | -79.08M | -23.78M | -42.72M | 2.75M |
Change in Receivables | -9.12M | -25.76M | -25.03M | -8.29M | -21.34M | -69.86M | -266K | 26.6M | -19.51M | -14.52M |
Change in Inventory | -18.83M | -22.29M | -41.41M | -56.98M | -51.55M | -74.63M | -67.71M | -65.66M | -26.48M | -24.74M |
Change in Payables | 1.85M | 1.33M | 6.04M | -308K | -1.56M | 13.38M | 1.1M | 4.17M | 3.07M | 12.28M |
Cash from Investing | -77.65M | -385K | -11.91M | -104.15M | -21.73M | 54.79M | -16.08M | 77.62M | -404.59M | -434.72M |
Capital Expenditures | -15.03M | -9.6M | -22.11M | -24.76M | -21.18M | -19.3M | -15.21M | -21.18M | -63.73M | -63.93M |
CapEx % of Revenue | 4.5% | 2.16% | 4.04% | 4.42% | 2.83% | 2.28% | 1.44% | 1.77% | 4.54% | 4.4% |
Acquisitions | -9.25M | -20.41M | 800K | 0 | 2.92M | 0 | -988K | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -55.87M | 29.63M | -8.64M | -3.06M | -400K | 0 | -500K | 1.1M | 0 | -1M |
Cash from Financing | 104.36M | -9.81M | -9.76M | 134.92M | 836K | 11.62M | 16.2M | -87.01M | 26.53M | 21.92M |
Debt Issued (Net) | -1.08M | -404K | -2.57M | -3.42M | -1.45M | -1.75M | -1.98M | -2.28M | -2.48M | -2.49M |
Equity Issued (Net) | 106.27M | 0 | 13.1M | 134.76M | 18.37M | 21.55M | 20.41M | -100.39M | 31.82M | 27.8M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | -17.73M | 0 | 0 | 0 | 0 | 0 | -100.39M | 0 | 0 |
Other Financing | -829K | -9.41M | -20.29M | 3.58M | -16.08M | -8.18M | -2.23M | 15.66M | -2.8M | -3.39M |
Net Change in Cash | 37.4M▲ 0% | 17.21M▼ 54.0% | 4.93M▼ 71.4% | -3.11M▼ 163.1% | -10.29M▼ 231.0% | 10.48M▲ 201.8% | 97.63M▲ 831.7% | 156.92M▲ 60.7% | -137.51M▼ 187.6% | -134.76M▲ 0% |
Free Cash Flow | -2.34M▲ 0% | 19.2M▲ 920.4% | 4.54M▼ 76.3% | -58M▼ 1376.6% | -11.68M▲ 79.9% | -74.96M▼ 541.9% | 82.12M▲ 209.6% | 147.3M▲ 79.4% | 174.93M▲ 18.8% | 212.73M▲ 0% |
FCF Margin % | -0.7% | 4.32% | 0.83% | -10.35% | -1.56% | -8.85% | 7.76% | 12.33% | 12.46% | 14.63% |
FCF Growth % | 91.15% | 920.38% | -76.34% | -1376.65% | 79.86% | -541.88% | 209.55% | 79.37% | 18.76% | 41.51% |
FCF per Share | -0.07 | 0.53 | 0.13 | -1.62 | -0.31 | -1.98 | 2.09 | 3.75 | 4.45 | 5.38 |
FCF Conversion (FCF/Net Income) | 2.73x | 4.36x | 0.55x | 2.12x | 1.80x | 27.80x | 1.07x | 12.02x | 1.34x | 1.24x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 141K | 156K | 0 | 1.41M | 0 | 0 | 0 | 20.67M | 0 | 7.08M |
PEN Key Ratios
Penumbra, Inc. (PEN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 1.4% | 1.6% | 10.67% | -2.8% | 0.66% | -0.21% | 8.35% | 1.2% | 13.78% | 12.32% |
Return on Invested Capital (ROIC) | 0.29% | -0.18% | 8.39% | -5.12% | -0.66% | 0.41% | 4.58% | 0.61% | 11.31% | 10.68% |
Gross Margin | 65.06% | 65.75% | 67.95% | 60.34% | 63.59% | 63.18% | 64.49% | 63.2% | 67.14% | 67.38% |
Net Margin | 1.4% | 1.48% | 8.85% | -2.8% | 0.71% | -0.24% | 8.59% | 1.17% | 12.66% | 11.76% |
Debt / Equity | - | - | 0.17x | 0.12x | 0.18x | 0.24x | 0.20x | 0.19x | 0.15x | 0.15x |
Interest Coverage | - | - | - | - | -4.43x | 3.23x | 46.80x | 15.72x | - | 304.65x |
FCF Conversion | 2.73x | 4.36x | 0.55x | 2.12x | 1.80x | 27.80x | 1.07x | 12.02x | 1.34x | 1.24x |
Revenue Growth | 26.75% | 33.31% | 23.03% | 2.38% | 33.4% | 13.32% | 24.95% | 12.86% | 17.5% | 17.27% |
Related:PEN Dividend History·PEN Revenue History·PEN Price History·PEN P/E History·PEN Financial Ratios·PEN Institutional Holders
PEN SEC Filings & Documents
Penumbra, Inc. (PEN) SEC filings — annual & quarterly reports (10-K, 10-Q)
PEN Frequently Asked Questions
Penumbra, Inc. (PEN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Penumbra, Inc. (PEN) reported $1.45B in revenue for fiscal year 2025. This represents a 1537% increase from $88.8M in 2013.
Penumbra, Inc. (PEN) grew revenue by 17.5% over the past year. This is strong growth.
Yes, Penumbra, Inc. (PEN) is profitable, generating $171.0M in net income for fiscal year 2025 (12.7% net margin).
Dividend & Returns
Penumbra, Inc. (PEN) has a return on equity (ROE) of 13.8%. This is reasonable for most industries.
Penumbra, Inc. (PEN) generated $212.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.